183 related articles for article (PubMed ID: 11144528)
1. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
3. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas.
Nakamura E; Sugihara H; Bamba M; Hattori T
J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444
[TBL] [Abstract][Full Text] [Related]
4. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
5. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
6. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Aihara R; Mochiki E; Nakabayashi T; Akazawa K; Asao T; Kuwano H
Br J Surg; 2005 Apr; 92(4):454-62. PubMed ID: 15609380
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
9. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells.
Shibata T; Ochiai A; Kanai Y; Akimoto S; Gotoh M; Yasui N; Machinami R; Hirohashi S
Oncogene; 1996 Sep; 13(5):883-9. PubMed ID: 8806677
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis.
Ougolkov A; Yamashita K; Bilim V; Takahashi Y; Mai M; Minamoto T
Int J Colorectal Dis; 2003 Mar; 18(2):160-6. PubMed ID: 12548420
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
14. Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Aihara R; Mochiki E; Kamiyama Y; Ohno T; Asao T; Kuwano H
J Surg Oncol; 2006 May; 93(6):491-7. PubMed ID: 16615152
[TBL] [Abstract][Full Text] [Related]
15. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
16. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastasis in multiple synchronous early gastric cancer.
Choi J; Kim SG; Im JP; Kang SJ; Lee HJ; Yang HK; Kim JS; Kim WH; Jung HC; Song IS
Gastrointest Endosc; 2011 Aug; 74(2):276-84. PubMed ID: 21802585
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of nuclear β-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis.
Wang L; Cheng H; Liu Y; Wang L; Yu W; Zhang G; Chen B; Yu Z; Hu S
Ann Surg Oncol; 2011 Jun; 18(6):1553-9. PubMed ID: 21207157
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]